Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction.
<h4>Background</h4>Lipoatrophy and/or central fat gain are observed frequently in patients on antiretroviral therapy (ART). Both are assumed to be antiretroviral adverse drug reactions.<h4>Methods</h4>We conducted a systematic review to determine whether fat loss or gain was...
Saved in:
| Main Authors: | Reneé de Waal, Karen Cohen, Gary Maartens |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0063623 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Adverse Drug Reaction Profile of Drugs Used as First-Line Antiretroviral Therapy
by: Mukta N. Chowta, et al.
Published: (2018-01-01) -
Evaluation of Surveillance System for Adverse Drug Reaction Due to Antiretroviral Drugs, Mazowe District, Zimbabwe, 2021
by: Godwin Choga, et al.
Published: (2025-01-01) -
Lipodystrophy induced by combination antiretroviral therapy in HIV/AIDS patients: A Belgrade cohort study
by: Dragović Gordana, et al.
Published: (2014-01-01) -
Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program
by: Tinashe Mudzviti, et al.
Published: (2012-11-01) -
Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
by: Martine Caron, et al.
Published: (2009-01-01)